Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitisAmir Karban, Steven R. Brant, Mark S. Silverberg et al.|Human Molecular Genetics|2003Cited by 337
Contribution of higher risk genes and European admixture to Crohnʼs disease in African AmericansMing‐Hsi Wang, Steven R. Brant, Toshihiko Okazaki et al.|Inflammatory Bowel Diseases|2012Cited by 32
A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumorsYasuki Hijikata, Kenzaburo Tani, Toshihiko Okazaki et al.|PLoS ONE|2018Cited by 17